Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ying, S. H.
Right arrow Articles by Toga, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ying, S. H.
Right arrow Articles by Toga, A. W.
Related Collections
Right arrow MRI
Right arrow Volumetric MRI
Right arrow Gait disorders/ataxia
NEUROLOGY 2006;66:424-426
© 2006 American Academy of Neurology


Brief Communications

Pontine and cerebellar atrophy correlate with clinical disability in SCA2

S. H. Ying, MD, S. I. Choi, BS, S. L. Perlman, MD, R. W. Baloh, MD, D. S. Zee, MD and A. W. Toga, PhD

From Johns Hopkins University School of Medicine (S.H.Y., S.I.C., D.S.Z.), Baltimore, MD; University of California, Los Angeles, School of Medicine (S.L.P., R.W.B., A.W.T.).

Address correspondence and reprint requests to Dr. Sarah H. Ying, Pathology 2-210, 600 North Wolfe Street, Baltimore, MD 21287; e-mail: sying{at}dizzy.med.jhu.edu

Spinocerebellar ataxia type 2 (SCA2) has protean manifestations, and a clinical marker of progression is needed. Although MRI is a promising tool, it is unclear whether the degree of atrophy shown on MRI is correlated with clinical dysfunction. Here the authors used high-resolution volumetric MRI analysis to show that cerebellar and pontine volumes specifically and closely correlate with functional staging scores.


Supported by the Arnold-Chiari Foundation, Robin Zee Fund, NIH grants 5T32DC000023-20, 5T32MH019950-07, 5T32GM007057-28, and EY01849.

Disclosure: The authors report no conflicts of interest.

Received March 21, 2005. Accepted in final form October 27, 2005.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.